Duke Cancer Institute- Duke University Medical Center
Durham, North Carolina 27710
We've found
1 trials
at this facility
Breast Neoplasms Clinical Trial
Updated: 12/31/1969
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials